Dr. Neil Berinstein

My research revolves around using molecular genetic techniques to augment the immunogenicity of murine and human B lymphoma cells as an immunotherapeutic approach. Strategies effecitve in the murine model will be translated to clinical trials both independantly and as an adjuvant post autologous transplantation.

[email protected]